← Back to Search

Plant-Based Diet for Endometriosis

N/A
Recruiting
Led By Hana Kahleova, MD, PhD
Research Sponsored by Physicians Committee for Responsible Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with a surgical, imaging, or clinical diagnosis of endometriosis
Age 18-45 years
Must not have
Unstable medical or psychiatric illness
Hysterectomy or ovariectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and at 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of a low-fat plant-based diet to no change in diet in women with endometriosis.

Who is the study for?
This trial is for women aged 18-45 with endometriosis confirmed by surgery, imaging, or clinical diagnosis. Participants should be in stable health and not have had any changes to their medications in the past three months. They must have a certain level of pelvic pain and be willing to potentially switch to a plant-based diet for 12 weeks.
What is being tested?
The study compares the effects of a low-fat plant-based diet versus usual diets over 12 weeks on women with endometriosis. It measures changes in pain, quality of life, inflammatory markers, body weight, blood lipids, gut microbiome composition, and hormonal levels without altering exercise habits.
What are the potential side effects?
While specific side effects are not listed for this nutritional intervention trial, participants may experience digestive adjustments due to dietary changes such as bloating or gas when starting a plant-based diet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with endometriosis.
Select...
I am between 18 and 45 years old.
Select...
My health and medications have been stable for the last 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any unstable medical or mental health conditions.
Select...
I have had a hysterectomy or ovariectomy.
Select...
I have a condition like Cushing's, Hashimoto's, Graves', type 1 diabetes, or Addison's.
Select...
I am not fluent in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and at 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Endometriosis Health Profile (EHP-30): change from baseline
Inflammatory biomarkers: change from baseline
Modified Biberoglu and Behrman Scale: change from baseline
Secondary study objectives
Biomarkers of endometriosis and inflammation: change from baseline
Blood lipids: change from baseline
Body weight: change from baseline
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Plant-based Intervention GroupExperimental Treatment1 Intervention
Intervention group participants will adopt a low-fat, plant-based diet for 12 weeks. Participants will be provided with a commercially available supplement containing 100 micrograms of vitamin B12 and asked to take it daily during the study. Alcoholic beverages will be limited to 1 per day. Participants will be asked to keep their physical activity level constant.
Group II: Control GroupActive Control1 Intervention
Control group participants will be asked to maintain their usual diet for the duration of the 12-week study period. Participants will be provided with a commercially available supplement containing 100 micrograms of vitamin B12 and asked to take it daily during the study. Alcoholic beverages will be limited to 1 per day. Participants will be asked to keep their physical activity level constant. At the conclusion of the 12 weeks, control group participants will be offered instruction in the plant-based diet.

Find a Location

Who is running the clinical trial?

Physicians Committee for Responsible MedicineLead Sponsor
29 Previous Clinical Trials
2,505 Total Patients Enrolled
Hana Kahleova, MD, PhDPrincipal InvestigatorPhysicians Committee for Responsible Medicine
3 Previous Clinical Trials
115 Total Patients Enrolled
Neal Barnard, MDStudy DirectorPhysicians Committee for Responsible Medicine
9 Previous Clinical Trials
1,173 Total Patients Enrolled

Media Library

Plant-based Intervention Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05175248 — N/A
~28 spots leftby Nov 2025